30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

CTI Biopharma Corp (CTIC)

Track

Stock chart
Ticker: CTIC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Fong James K
EVP & Chief Commercial Officer
1 sale — total 600,000 USD
Planned sale 24 Jan 2023
Value US$3,264,028.76 | Price 300.39 | Shares 49,657
Planned sale 24 Jan 2023
Value US$976,633.56 | Price 334.57 | Shares 69,478
Planned sale 24 Jan 2023
Value US$29,020.53 | Price 289.69 | Shares 5,833
Planned sale 3 Jan 2023
Value US$162,423.23 | Price 6.01 | Shares 27,021
Planned sale 3 Jan 2023
Value US$509,224.28 | Price 6.01 | Shares 84,683
Planned sale 30 Dec 2022
Value US$6,292.47 | Price 6.01 | Shares 1,047
Planned sale 30 Dec 2022
Value US$4,804.00 | Price 6.01 | Shares 800
Planned sale 30 Dec 2022
Value US$72,000.00 | Price 6.00 | Shares 12,000
Planned sale 30 Dec 2022
Value US$26,444.00 | Price 6.01 | Shares 4,400
Planned sale 30 Dec 2022
Value US$4,203.50 | Price 6.01 | Shares 700
Planned sale 30 Dec 2022
Value US$72,000.00 | Price 6.00 | Shares 12,000
Planned sale 29 Dec 2022
Value US$79,044.00 | Price 6.00 | Shares 13,174
Planned sale 29 Dec 2022
Value US$82,800.00 | Price 6.00 | Shares 13,800
Planned sale 10 Nov 2022
Value US$16,308.00 | Price 6.04 | Shares 2,700
Planned sale 10 Nov 2022
Value US$34,974.00 | Price 6.03 | Shares 5,800
Planned sale 10 Nov 2022
Value US$98,703.92 | Price 6.02 | Shares 16,396
Planned sale 10 Nov 2022
Value US$601.50 | Price 6.02 | Shares 100
Planned sale 10 Nov 2022
Value US$160,467.00 | Price 6.01 | Shares 26,700
Planned sale 10 Nov 2022
Value US$1,201.00 | Price 6.01 | Shares 200
Planned sale 10 Nov 2022
Value US$818,448.00 | Price 6.00 | Shares 136,408
Planned sale 9 Nov 2022
Value US$1,804.50 | Price 6.02 | Shares 300
Planned sale 9 Nov 2022
Value US$45,651.96 | Price 6.01 | Shares 7,596
Planned sale 9 Nov 2022
Value US$276,600.00 | Price 6.00 | Shares 46,100
Planned sale 8 Nov 2022
Value US$25,659.90 | Price 5.70 | Shares 4,500
Planned sale 8 Nov 2022
Value US$208,578.23 | Price 5.65 | Shares 36,942
Planned sale 8 Nov 2022
Value US$276,780.69 | Price 5.53 | Shares 50,058
Planned sale 4 Oct 2022
Value US$3,818.43 | Price 6.27 | Shares 609
Planned sale 4 Oct 2022
Value US$626.00 | Price 6.26 | Shares 100
Planned sale 4 Oct 2022
Value US$8,750.00 | Price 6.25 | Shares 1,400
Planned sale 3 Oct 2022
Value US$1,875.00 | Price 6.25 | Shares 300
Planned sale 30 Sep 2022
Value US$845,548.61 | Price 6.05 | Shares 139,841
Planned sale 29 Sep 2022
Value US$601.00 | Price 6.01 | Shares 100
Planned sale 29 Sep 2022
Value US$4,800.00 | Price 6.00 | Shares 800
Planned sale 16 Sep 2022
Value US$136,003.84 | Price 6.02 | Shares 22,592
Planned sale 12 Sep 2022
Value US$1,557,989.00 | Price 6.43 | Shares 242,300
Buy 16 Aug 2022
Value US$27,500.00 | Price 5.50 | Shares 5,000
Sale 9 Aug 2022
Value US$7,891,336.08 | Price 6.12 | Shares 1,289,434
Sale 9 Aug 2022
Value US$2,870,524.80 | Price 6.12 | Shares 469,040
Sale 9 Aug 2022
Value US$17,691,224.76 | Price 6.12 | Shares 2,890,723
Sale 9 Aug 2022
Value US$23,566,914.36 | Price 6.12 | Shares 3,850,803
Planned sale 7 Jul 2022
Value US$7,205.00 | Price 6.55 | Shares 1,100
Planned sale 7 Jul 2022
Value US$2,616.00 | Price 6.54 | Shares 400
Planned sale 7 Jul 2022
Value US$2,612.00 | Price 6.53 | Shares 400
Planned sale 7 Jul 2022
Value US$21,652.92 | Price 6.52 | Shares 3,321
Planned sale 7 Jul 2022
Value US$38,409.00 | Price 6.51 | Shares 5,900
Planned sale 7 Jul 2022
Value US$58,500.00 | Price 6.50 | Shares 9,000
Planned sale 6 Jul 2022
Value US$111,342.53 | Price 6.11 | Shares 18,223
Planned sale 5 Jul 2022
Value US$20,737.14 | Price 6.23 | Shares 3,331
Planned sale 5 Jul 2022
Value US$168,895.09 | Price 6.14 | Shares 27,506
Planned sale 5 Jul 2022
Value US$314,438.51 | Price 6.05 | Shares 51,963
Planned sale 5 Jul 2022
Value US$51,996.42 | Price 5.98 | Shares 8,700
Planned sale 5 Jul 2022
Value US$162,000.00 | Price 6.00 | Shares 27,000
Planned sale 1 Jul 2022
Value US$162,000.00 | Price 6.00 | Shares 27,000
Planned sale 17 Jun 2022
Value US$312,505.00 | Price 6.25 | Shares 50,000
Planned sale 17 Jun 2022
Value US$60,000.00 | Price 6.00 | Shares 10,000
Planned sale 14 Jun 2022
Value US$55,000.00 | Price 5.50 | Shares 10,000
Planned sale 3 Jun 2022
Value US$109,520.23 | Price 6.01 | Shares 18,223
Planned sale 2 Jun 2022
Value US$162,000.00 | Price 6.00 | Shares 27,000
Planned sale 1 Jun 2022
Value US$162,000.00 | Price 6.00 | Shares 27,000
Buy 2 Dec 2021
Value US$3,321.45 | Price 1.53 | Shares 2,178
Buy 2 Dec 2021
Value US$2,015.92 | Price 1.52 | Shares 1,322
Buy 1 Apr 2021
Value US$12,927.50 | Price 2.50 | Shares 5,171
Buy 1 Apr 2021
Value US$2,375,040.00 | Price 2.50 | Shares 950,016
Buy 1 Apr 2021
Value US$2,612,032.50 | Price 2.50 | Shares 1,044,813
Sale 7 Jan 2021
Value US$7,000,000.00 | Price 3.50 | Shares 2,000,000
Buy 9 Feb 2018
Value US$2,097,675.00 | Price 3.00 | Shares 699,225
Buy 9 Feb 2018
Value US$1,451,124.00 | Price 3.00 | Shares 483,708
Buy 9 Feb 2018
Value US$6,327,840.00 | Price 3.00 | Shares 2,109,280
Buy 9 Feb 2018
Value US$9,123,360.00 | Price 3.00 | Shares 3,041,120
Sale 29 Sep 2017
Value US$3,123.20 | Price 3.20 | Shares 976
Sale 28 Sep 2017
Value US$650.00 | Price 3.25 | Shares 200
Sale 28 Sep 2017
Value US$1,545.48 | Price 3.24 | Shares 477
Sale 28 Sep 2017
Value US$647.00 | Price 3.24 | Shares 200
Sale 28 Sep 2017
Value US$5,168.16 | Price 3.23 | Shares 1,600
Sale 28 Sep 2017
Value US$5,410.25 | Price 3.23 | Shares 1,675
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-26 2023-01-24 PlS Planned sale
Fong James K

EVP & Chief Commercial Officer

Officer
49,657 +45.4%
300.39
US$3,264,029 		49,657 +45.4% 300.39 US$3,264,029
2023-01-26 2023-01-24 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
69,478 -22.2%
334.57
US$976,634 		69,478 -22.2% 334.57 US$976,634
2023-01-26 2023-01-24 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
5,833 -11.8%
289.69
US$29,021 		5,833 -11.8% 289.69 US$29,021
2023-01-03 2023-01-03 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
27,021 -61.2%
6.01
US$162,423 		27,021 -61.2% 6.01 US$162,423
2023-01-03 2023-01-03 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
84,683 -74.2%
6.01
US$509,224 		84,683 -74.2% 6.01 US$509,224
2023-01-03 2022-12-30 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
1,047 -5.8%
6.01
US$6,292 		1,047 -5.8% 6.01 US$6,292
2023-01-03 2022-12-30 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
800 -4.5%
6.01
US$4,804 		800 -4.5% 6.01 US$4,804
2023-01-03 2022-12-30 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
12,000 -41.2%
6.00
US$72,000 		12,000 -41.2% 6.00 US$72,000
2023-01-03 2022-12-30 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
4,400 -13.0%
6.01
US$26,444 		4,400 -13.0% 6.01 US$26,444
2023-01-03 2022-12-30 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
700 -2.3%
6.01
US$4,204 		700 -2.3% 6.01 US$4,204
2023-01-03 2022-12-30 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
12,000 -29.0%
6.00
US$72,000 		12,000 -29.0% 6.00 US$72,000
2023-01-03 2022-12-29 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
13,174 -43.8%
6.00
US$79,044 		13,174 -43.8% 6.00 US$79,044
2023-01-03 2022-12-29 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
13,800 -33.1%
6.00
US$82,800 		13,800 -33.1% 6.00 US$82,800
2022-11-14 2022-11-10 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
2,700 -8.8%
6.04
US$16,308 		2,700 -8.8% 6.04 US$16,308
2022-11-14 2022-11-10 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
5,800 -16.0%
6.03
US$34,974 		5,800 -16.0% 6.03 US$34,974
2022-11-14 2022-11-10 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
16,396 -31.1%
6.02
US$98,704 		16,396 -31.1% 6.02 US$98,704
2022-11-14 2022-11-10 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
100 -0.2%
6.02
US$602 		100 -0.2% 6.02 US$602
2022-11-14 2022-11-10 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
26,700 -33.6%
6.01
US$160,467 		26,700 -33.6% 6.01 US$160,467
2022-11-14 2022-11-10 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
200 -0.3%
6.01
US$1,201 		200 -0.3% 6.01 US$1,201
2022-11-14 2022-11-10 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
136,408 -63.1%
6.00
US$818,448 		136,408 -63.1% 6.00 US$818,448
2022-11-14 2022-11-09 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
300 -1.1%
6.02
US$1,804 		300 -1.1% 6.02 US$1,804
2022-11-14 2022-11-09 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
7,596 -21.2%
6.01
US$45,652 		7,596 -21.2% 6.01 US$45,652
2022-11-14 2022-11-09 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
46,100 -56.3%
6.00
US$276,600 		46,100 -56.3% 6.00 US$276,600
2022-11-10 2022-11-08 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
4,500 -100.0%
5.70
US$25,660 		4,500 -100.0% 5.70 US$25,660
2022-11-10 2022-11-08 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
36,942 -89.1%
5.65
US$208,578 		36,942 -89.1% 5.65 US$208,578
2022-11-10 2022-11-08 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
50,058 -54.7%
5.53
US$276,781 		50,058 -54.7% 5.53 US$276,781
2022-10-06 2022-10-04 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
609 -3.5%
6.27
US$3,818 		609 -3.5% 6.27 US$3,818
2022-10-06 2022-10-04 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
100 -0.6%
6.26
US$626 		100 -0.6% 6.26 US$626
2022-10-06 2022-10-04 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
1,400 -7.6%
6.25
US$8,750 		1,400 -7.6% 6.25 US$8,750
2022-10-03 2022-10-03 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
300 -1.7%
6.25
US$1,875 		300 -1.7% 6.25 US$1,875
2022-10-03 2022-09-30 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
139,841 -89.2%
6.05
US$845,549 		139,841 -89.2% 6.05 US$845,549
2022-10-03 2022-09-29 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
100 -0.6%
6.01
US$601 		100 -0.6% 6.01 US$601
2022-10-03 2022-09-29 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
800 -4.5%
6.00
US$4,800 		800 -4.5% 6.00 US$4,800
2022-09-20 2022-09-16 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
22,592 -57.2%
6.02
US$136,004 		22,592 -57.2% 6.02 US$136,004
2022-09-14 2022-09-12 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
242,300 -89.7%
6.43
US$1,557,989 		242,300 -89.7% 6.43 US$1,557,989
2022-08-16 2022-08-16 B Purchase
4.0
Craig Adam R

President and CEO

Executive Director
5,000 +21.9%
5.50
US$27,500 		5,000 +21.9% 5.50 US$27,500
2022-08-11 2022-08-09 S Sale
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
1,289,434 -99.5%
6.12
US$7,891,336 		1,289,434 -99.5% 6.12 US$7,891,336
2022-08-11 2022-08-09 S Sale
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
469,040 -95.9%
6.12
US$2,870,525 		469,040 -95.9% 6.12 US$2,870,525
2022-08-11 2022-08-09 S Sale
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
2,890,723 -94.5%
6.12
US$17,691,225 		2,890,723 -94.5% 6.12 US$17,691,225
2022-08-11 2022-08-09 S Sale
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
3,850,803 -94.2%
6.12
US$23,566,914 		3,850,803 -94.2% 6.12 US$23,566,914
2022-07-11 2022-07-07 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
1,100 -100.0%
6.55
US$7,205 		1,100 -100.0% 6.55 US$7,205
2022-07-11 2022-07-07 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
400 -26.7%
6.54
US$2,616 		400 -26.7% 6.54 US$2,616
2022-07-11 2022-07-07 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
400 -21.1%
6.53
US$2,612 		400 -21.1% 6.53 US$2,612
2022-07-11 2022-07-07 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
3,321 -63.6%
6.52
US$21,653 		3,321 -63.6% 6.52 US$21,653
2022-07-11 2022-07-07 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
5,900 -53.1%
6.51
US$38,409 		5,900 -53.1% 6.51 US$38,409
2022-07-11 2022-07-07 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
9,000 -44.7%
6.50
US$58,500 		9,000 -44.7% 6.50 US$58,500
2022-07-06 2022-07-06 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
18,223 -44.4%
6.11
US$111,343 		18,223 -44.4% 6.11 US$111,343
2022-07-07 2022-07-05 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
3,331 -14.2%
6.23
US$20,737 		3,331 -14.2% 6.23 US$20,737
2022-07-07 2022-07-05 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
27,506 -54.0%
6.14
US$168,895 		27,506 -54.0% 6.14 US$168,895
2022-07-07 2022-07-05 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
51,963 -50.5%
6.05
US$314,439 		51,963 -50.5% 6.05 US$314,439
2022-07-07 2022-07-05 PlS Planned sale
2.7
Metzger Michael A
Non-Executive Director
8,700 -7.8%
5.98
US$51,996 		8,700 -7.8% 5.98 US$51,996
2022-07-06 2022-07-05 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
27,000 -54.2%
6.00
US$162,000 		27,000 -54.2% 6.00 US$162,000
2022-07-06 2022-07-01 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
27,000 -54.2%
6.00
US$162,000 		27,000 -54.2% 6.00 US$162,000
2022-06-17 2022-06-17 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
50,000 -87.1%
6.25
US$312,505 		50,000 -87.1% 6.25 US$312,505
2022-06-17 2022-06-17 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
10,000 -57.5%
6.00
US$60,000 		10,000 -57.5% 6.00 US$60,000
2022-06-16 2022-06-14 PlS Planned sale
KIRSKE DAVID

EVP, Chief Financial Officer

Officer
10,000 -57.5%
5.50
US$55,000 		10,000 -57.5% 5.50 US$55,000
2022-06-03 2022-06-03 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
18,223 -52.2%
6.01
US$109,520 		18,223 -52.2% 6.01 US$109,520
2022-06-03 2022-06-02 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
27,000 -61.8%
6.00
US$162,000 		27,000 -61.8% 6.00 US$162,000
2022-06-03 2022-06-01 PlS Planned sale
4.0
Craig Adam R

President and CEO

Executive Director
27,000 -61.8%
6.00
US$162,000 		27,000 -61.8% 6.00 US$162,000
2021-12-02 2021-12-02 B Purchase
4.0
Craig Adam R

President and CEO

Executive Director
2,178 +19.2%
1.53
US$3,321 		2,178 +19.2% 1.53 US$3,321
2021-12-02 2021-12-02 B Purchase
4.0
Craig Adam R

President and CEO

Executive Director
1,322 +13.2%
1.52
US$2,016 		1,322 +13.2% 1.52 US$2,016
2021-04-05 2021-04-01 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
5,171 +1.1%
2.50
US$12,928 		5,171 +1.1% 2.50 US$12,928
2021-04-05 2021-04-01 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
950,016 +45.0%
2.50
US$2,375,040 		950,016 +45.0% 2.50 US$2,375,040
2021-04-05 2021-04-01 B Purchase
4.0
BVF PARTNERS L P/IL
Non-Executive Director Large shareholder
1,044,813 +34.4%
2.50
US$2,612,032 		1,044,813 +34.4% 2.50 US$2,612,032
2021-01-11 2021-01-07 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
2,000,000 -21.0%
3.50
US$7,000,000 		2,000,000 -21.0% 3.50 US$7,000,000
2018-02-12 2018-02-09 B Purchase BVF PARTNERS L P/IL Large shareholder
699,225 +117.2%
3.00
US$2,097,675 		699,225 +117.2% 3.00 US$2,097,675
2018-02-12 2018-02-09 B Purchase BVF PARTNERS L P/IL Large shareholder
483,708 +inf%
3.00
US$1,451,124 		483,708 +inf% 3.00 US$1,451,124
2018-02-12 2018-02-09 B Purchase BVF PARTNERS L P/IL Large shareholder
2,109,280 +inf%
3.00
US$6,327,840 		2,109,280 +inf% 3.00 US$6,327,840
2018-02-12 2018-02-09 B Purchase BVF PARTNERS L P/IL Large shareholder
3,041,120 +inf%
3.00
US$9,123,360 		3,041,120 +inf% 3.00 US$9,123,360
2017-10-02 2017-09-29 S Sale LOVE RICHARD L Non-Executive Director
976 -1.3%
3.20
US$3,123 		976 -1.3% 3.20 US$3,123
2017-10-02 2017-09-28 S Sale LOVE RICHARD L Non-Executive Director
200 -0.3%
3.25
US$650 		200 -0.3% 3.25 US$650
2017-10-02 2017-09-28 S Sale LOVE RICHARD L Non-Executive Director
477 -0.6%
3.24
US$1,545 		477 -0.6% 3.24 US$1,545
2017-10-02 2017-09-28 S Sale LOVE RICHARD L Non-Executive Director
200 -0.3%
3.24
US$647 		200 -0.3% 3.24 US$647
2017-10-02 2017-09-28 S Sale LOVE RICHARD L Non-Executive Director
1,600 -2.1%
3.23
US$5,168 		1,600 -2.1% 3.23 US$5,168
2017-10-02 2017-09-28 S Sale LOVE RICHARD L Non-Executive Director
1,675 -2.1%
3.23
US$5,410 		1,675 -2.1% 3.23 US$5,410
Explore more

More insider trading research around CTI Biopharma Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America